metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Información de la revista
Número
Vol. 29. Núm. 6.
(noviembre - diciembre 2024)
Editorial board
Ann Hepatol. 2024;29:101592
Acceso a texto completo
Editorial
Gilberta Bensabath – Centenary of the discoverer of the high prevalence of hepatitis B and Delta in the Amazon – On the path to elimination as a public health problem!
João Renato Rebello Pinho, Michele Gomes-Gouvêa, Flair José Carrilho
Ann Hepatol. 2024;29:101575
Acceso a texto completo
Opinions
Global multi-societies endorsement of the MAFLD definition
Mohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, Dafina Nikolova, Enrique Carrera Estupiñan, Hasmik Ghazinyan, Sameer Alawadhi, Ponsiano Ocama, ... Yasser Fouad
Ann Hepatol. 2024;29:101573
Acceso a texto completo
Concise reviews
The myth of the stigma of fatty liver: What does the evidence show?
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Nahum Méndez-Sánchez
Ann Hepatol. 2024;29:101535
Acceso a texto completo
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
Jui-Hsiang Hung, Chiao-Feng Teng, Hsu-chin Hung, Yi-Lin Chen, Pin-Jun Chen, Chung-Liang Ho, Cheng-Hsiang Chuang, Wenya Huang
Ann Hepatol. 2024;29:101546
Acceso a texto completo
Original articles
CircROBO1 knockdown improves the radiosensitivity of hepatocellular carcinoma by regulating RAD21
Kai Yang, Yanpeng Ding, Jun Han, Rui He
Ann Hepatol. 2024;29:101536
Acceso a texto completo
Stroop test, Quickstroop, and the 1-min animal naming test for minimal hepatic encephalopathy diagnosis: A multicenter study in Mexico
Juan F. Ortiz-Treviño, Alma L. Kuljacha-Gastélum, Alejandro Tovar-Durán, Martha E. Wade-Isidro
Ann Hepatol. 2024;29:101531
Acceso a texto completo
Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein
Yuan Xu, Bei Zhang, Fan Zhou, Ying-ping Yi, Xin-Lei Yang, Xiao Ouyang, Hui Hu
Ann Hepatol. 2024;29:101540
Acceso a texto completo
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease
Facundo Maiorana, Magali Neschuk, María Virginia Caronia, Karina Elizondo, Adolfo Schneider, Georgina Veron, Pedro D Zapata, Fernando Javier Barreyro
Ann Hepatol. 2024;29:101541
Acceso a texto completo
Limited utility of routine bone scintigraphy in the staging of patients with hepatocellular carcinoma: A cross-sectional study
Fatima Rodriguez-Alvarez, Blanca Zuleima Mota-Ayala, Ramiro Villavicencio-Martínez, Eric Kauffman-Ortega, Lucero Selene Téllez-Morán, Graciela Castro-Narro, Eleazar Ignacio-Alvarez, Jesús Alejandro Gabutti-Thomas, Carlos Moctezuma-Velazquez
Ann Hepatol. 2024;29:101545
Acceso a texto completo
IL-6/STAT3 signaling pathway induces prostate apoptosis response protein-4(PAR-4) to stimulate malignant behaviors of hepatocellular carcinoma cells
Junnv Xu, Kun Liu, Zhixun Gong, Jinchen Liu, Haifeng Lin, Bo Lin, Wei Li, Mingyue Zhu, Mengsen Li
Ann Hepatol. 2024;29:101538
Acceso a texto completo
Hepatitis B virus X protein differentially regulates the angiogenesis of Hepatocellular Carcinoma through p53-VEGF axis according to glucose levels
Guitao Xiao, Xiaoyun Huang, Tingxuan Huang, Zhixin Chen, Yuehong Huang, Rongfeng Huang, Xiaozhong Wang
Ann Hepatol. 2024;29:101543
Acceso a texto completo
Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Adnan Malik, Sadia Javaid, Muhammad Imran Malik, Shahbaz Qureshi
Ann Hepatol. 2024;29:101544
Acceso a texto completo
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, Maria Papp, ... Kornelius Schulze
Ann Hepatol. 2024;29:101534
Acceso a texto completo
A novel role of AIM2 inflammasome-mediated pyroptosis in radiofrequency ablation of hepatocellular carcinoma
Feifan He, Zhongming He, Caoye Wang
Ann Hepatol. 2024;29:101532
Acceso a texto completo
Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases
Kamyar Ghabili, Austin-Marley Windham-Herman, Menelaos Konstantinidis, Nikitha Murali, Tabea Borde, Lucas C. Adam, Fabian Laage-Gaupp, MingDe Lin, ... Nariman Nezami
Ann Hepatol. 2024;29:101529
Acceso a texto completo
Letters to the editor
Predictors of poor postoperative outcomes in liver transplant patients
Osman Cagin Buldukoglu
Ann Hepatol. 2024;29:101574
Acceso a texto completo
An Acknowledgement
Ann Hepatol. 2024;29:101594
Acceso a texto completo
Artículo abierto
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos